Mycobacterium phage peptide (33-47)[K2V, S6L, L10S, G12W, A13W, W14K], AK15-6

General Information


DRACP ID  DRACP03814

Peptide Name   Mycobacterium phage peptide (33-47)[K2V, S6L, L10S, G12W, A13W, W14K], AK15-6

Sequence  AVKKLLRWWSRWWKK

Sequence Length  15

UniProt ID  Q1A0F2 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C103H155N29O17

Absent amino acids  CDEFGHIMNPQTY

Common amino acids  KW

Mass  232144

Pl  12.56

Basic residues  6

Acidic residues  0

Hydrophobic residues  8

Net charge  6

Boman Index  -3043

Hydrophobicity  -102.67

Aliphatic Index  78

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  22000

Absorbance 280nm  1571.43

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30894414

Title  A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12911

DRACP is developed by Dr.Zheng's team.